🇺🇸 FDA
Pipeline program

Phase 1 study on SAR443122 bioavailability and food effect in healthy adults

BDR17182

Phase 1 other active

Quick answer

Phase 1 study on SAR443122 bioavailability and food effect in healthy adults for Colitis ulcerative is a Phase 1 program (other) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pharma Bristol-Myers Squibb
Indication
Colitis ulcerative
Phase
Phase 1
Modality
other
Status
active

Clinical trials